# China NMPA Drug Inspection - Zhuhai Federal Pharmaceutical Co., Ltd. - Amoxicillin sodium clavulanate potassium (5:1)

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-federal-pharmaceutical-co-ltd/102132e2-343d-4f23-a856-25d43b6217d5/
Source feed: China

> China NMPA drug inspection for Zhuhai Federal Pharmaceutical Co., Ltd. published September 09, 2021. Drug: Amoxicillin sodium clavulanate potassium (5:1). 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2021)
- Company Name: Zhuhai Federal Pharmaceutical Co., Ltd.
- Publication Date: 2021-09-09
- Drug Name: Amoxicillin sodium clavulanate potassium (5:1)
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/zhuhai-federal-pharmaceutical-co-ltd/bb4825c4-f115-47da-9153-e81b46bcc131/